Testosterone replacement therapy faces FDA scrutiny

JAMA. 2015 Feb 10;313(6):563-4. doi: 10.1001/jama.2014.17334.
No abstract available

MeSH terms

  • Adult
  • Advisory Committees
  • Aged
  • Cardiovascular Diseases / chemically induced*
  • Drug Approval*
  • Drug Labeling*
  • Hormone Replacement Therapy / adverse effects*
  • Humans
  • Hypogonadism / drug therapy*
  • Male
  • Middle Aged
  • Testosterone / adverse effects
  • Testosterone / blood
  • Testosterone / therapeutic use*
  • United States
  • United States Food and Drug Administration

Substances

  • Testosterone